Drug discontinuation: Riboflavin 5-phosphate Ophthalmic Solution (PHOTREXA CROSS-LINKING KIT)
FDA lists 1 presentation as To Be Discontinued. Companies: Glaukos Corporation.
- Published by source
- 2026-01-20
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Glaukos Corporation
- Products
- Riboflavin 5-phosphate Ophthalmic Solution PHOTREXA CROSS-LINKING KIT
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Discontinuing manufacture of the product as of July 2026.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-01-20
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #1014 | new | 2026-10-22 | 9e18d05d24bc…0a12fe | 3765b9acd17c…3675fb |
Chain head: #1076 8ad5adc30b9b…88ce20